Infection Flashcards
COVID-19?
infectious disease caused by the novel coronavirus SARS-CoV-2, first identified in Wuhan, China, in late 2019. It has led to a global pandemic with significant morbidity and mortality.
COVID-19 presents with?
wide spectrum of clinical manifestations, from asymptomatic to severe respiratory failure and multi-organ dysfunction.
Cause of COVID-19?
Causative Agent: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Transmission of COVID-19?
Primarily via respiratory droplets
Contact with contaminated surfaces
Aerosol transmission in certain settings
Pathophysiology of COVID-19?
Virus binds to the ACE2 receptor on host cells, facilitating entry and replication
Causes a range of immune responses from mild inflammation to cytokine storm
Predominantly affects the respiratory system but can involve multiple organ systems
Clinical features of COVID-19?
Common: Fever, cough, fatigue, loss of taste or smell, myalgia
Severe: Shortness of breath, chest pain, confusion, bluish lips or face
Other: Gastrointestinal symptoms (nausea, diarrhoea), dermatological manifestations
COVID-19 disease course?
Incubation period: 2-14 days, median 5 days
Mild to moderate illness: Majority of cases
Severe illness: Occurs in approximately 14% of cases, characterised by hypoxia and pneumonia
Critical illness: Approximately 5% of cases, involving respiratory failure, shock, and multi-organ dysfunction
COVID-19 incubation period?
2-14d, median 5d
Diagnosis of COVID-19?
Testing=
Reverse transcription polymerase chain reaction (RT-PCR): GOLD STANDARD for diagnosis, detects viral RNA
Antigen Tests: Useful for rapid diagnosis but less sensitive than RT-PCR
Serological Tests: Detect antibodies, used for assessing past infection and immune response
- CXR: May show bilateral infiltrates
- CT: More sensitive, can reveal ground-glass opacities and consolidation
COVID-19= what does CXR and CT show?
- CXR: May show bilateral infiltrates
- CT: More sensitive, can reveal ground-glass opacities and consolidation
COVID-19 gold standard for diagnosis?
Reverse transcription polymerase chain reaction (RT-PCR): detects viral RNA
Mx of COVID-19?
- general measures= isolation to prevent transmission; supportive- hydration, antipyretics, O2 therapy
- pharmacological Tx
- supportive care
Mx of COVID-19= supportive care?
Oxygen Therapy: Nasal cannula, high-flow nasal oxygen, non-invasive ventilation
Mechanical Ventilation: For patients with refractory hypoxia
Extracorporeal Membrane Oxygenation (ECMO): In cases of severe ARDS
Mx of COVID-19= pharmacological Tx?
Antivirals= Remdesivir for hospitalised patients requiring oxygen
Corticosteroids= Dexamethasone for hospitalised patients requiring oxygen
Immunomodulators= Baricitinib or tocilizumab in selected cases with systemic inflammation / requiring higher levels of oxygen
COVID-19= prevention and vaccination?
Vaccination is the cornerstone of prevention, with several vaccines approved for use in the UK (e.g., Pfizer-BioNTech, Moderna, AstraZeneca)
Booster doses recommended to maintain immunity, especially in vulnerable populations
Non-pharmacological interventions: Mask-wearing, hand hygiene, social distancing
Prognosis of COVID-19?
Prognostic Factors:
- Age, comorbidities (e.g., cardiovascular disease, diabetes, obesity), and severity of respiratory involvement
- Early intervention and supportive care improve outcomes
Outcomes:
- Recovery in mild to moderate cases usually within 2-6 weeks
- Long-term sequelae (Long COVID) in some patients, including fatigue, dyspnoea, cognitive impairment
Coronavirus disease (COVID-19) definition?
infectious disease caused by a novel betacoronavirus known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2).
‘Acute COVID-19’?
signs and symptoms of infection consistent with COVID-19 for up to 4 weeks
‘Ongoing symptomatic COVID-19’?
signs and symptoms of COVID-19 infection from 4–12 weeks
‘Post-COVID-19 syndrome’?
signs and symptoms that develop during or after an infection consistent with COVID-19, continue for more than 12 weeks, and are not explained by an alternative diagnosis.
‘Longer term effects of COVID-19’ or ‘long COVID’ ?
signs and symptoms that develop during or after an infection consistent with COVID-19, continue for more than 4 weeks, and are not explained by an alternative diagnosis.
Risk factors for severe infection of COVID-19?
increasing age, male sex, co-morbidities, health and social care workers, and Black and Asian ethnic groups.
Cx of COVID-19?
acute respiratory distress syndrome; venous thromboembolism; acute myocardial or kidney injury; and sepsis.
When to suspect COVID-19?
Fever or chills.
A new, continuous cough; breathlessness.
A loss or change to sense of smell or taste.
Fatigue; muscle aches and pains; headache.
Sore throat; blocked or runny nose.
Loss of appetite; diarrhoea; nausea and/or vomiting.